Amazon used its annual seller conference, Amazon Accelerate, to unveil new tools and fulfillment capabilities that underscore its ambition to serve as the infrastructure of retail. The retailer is weaving together AI-driven tools, externalized logistics, and its vast seller network to extend its influence beyond its own marketplace. As Amazon extends its reach through MCF and Buy with Prime, it increasingly sees merchants and marketplaces not as rivals but as collaborators.
Physicians’ views on pharmaceutical promotions have soured over the past several years, according to a recently published study in JAMA Health Forum. Doctors rely on drugmakers for resources on the latest medicines, but they don’t want this information to feel overly promotional. Pharma marketers and sales reps need to establish themselves as trustworthy and educational from the very beginning. They must make sure to ask doctors about patients’ needs, conditions, and their experiences with current and past treatments. Marketers can use that information to craft customized materials to show doctors how a drug will help their specific patients.
Gap, Reformation, Balenciaga, and Alo Yoga are expanding into new categories to futureproof their businesses amid uncertainty. As spending trends shift, fashion companies are trying to shift with them. Pushing into resilient categories like beauty and jewelry may look promising on paper, but success is not assured. Brands face considerable competition from companies with more experience, and convincing customers that new offerings deliver quality and value can be a challenge.
British pharma company GSK plans to invest $30 billion in US drug manufacturing and R&D, coinciding with President Trump’s UK state visit and a broader pullback on UK investments by other drugmakers. Since taking office, Trump has issued executive orders and warnings aimed at spurring more US manufacturing and lowering drug prices. While his approach is boosting manufacturing, it doesn’t necessarily translate to lower drug prices. For increased US manufacturing to truly benefit consumers, it needs to be coupled with reforms in how drugs are priced, negotiated, and reimbursed. Without cooperation from the full supply chain—from pharma companies to providers, pharmacy benefit managers, insurers, and federal and state governments—manufacturing growth alone won’t guarantee lower prices for patients.
America’s Health Insurance Plans (AHIP) released a statement that its member health insurers will cover vaccines that were previously recommended by the CDC’s advisory committee with no cost-sharing for patients through the end of 2026. AHIP’s commitment is the first real market signal that major insurers will keep paying for children’s immunizations, as well as updated formulations of COVID-19 and flu vaccines, even if the government’s vaccine advisory panel changes its recommendations. Insurers should partner up with medical associations, pharmacies, and vaccine makers to disseminate information at a local level that makes folks aware of their right to vaccine coverage under their health plan.
Younger generations' trust in drug companies is dropping. A new survey shows that many pharma companies are failing to connect with this audience on social media, where they look for health information. To win them back, pharma brands should create social media videos that highlight their history of innovation, rather than focusing on specific products. They can also partner with doctor influencers to create content that removes the stigma around topics like mental health and educates people on treatment options.
Nvidia is putting $5 billion into Intel, buying common stock at $23.28 per share for a 4%–5% stake. The two companies plan to co-develop custom PC and data center chips that blend Nvidia’s GPUs with Intel’s x86 CPUs and manufacturing muscle, per ABC News. For Intel, it’s a last chance to remain relevant in advanced computing. For Nvidia, it’s a strategic hedge—ensuring supply resilience and expanding influence over x86 chip design. The partnership will reshape the semiconductor industry and strengthen US tech leadership.
Marketers agree creative drives results, but many still struggle to define and scale it. Taylor Stewart, global head of retail media engagement at TripleLift, joins EMARKETER’s Arielle Feger to discuss how brands are closing the creative gap by using AI, testing roadmaps, and full-funnel strategies to turn ideas into measurable performance.
Meta is back in licensing talks with publishers like Axel Springer, Fox Corp., and News Corp., marking a reversal from its 2022 exit from news payments. The move comes as AI tools like Google’s AI Overviews cut publisher traffic, pushing outlets to secure compensation. Meanwhile, Reddit is pressing Google for richer terms, citing undervaluation of its human-authored content under existing $203 million contracts. For publishers, licensing deals provide revenue but risk cementing dependence on platforms that control discovery. For marketers, the shift highlights how AI-driven answers—rather than search results or feeds—are becoming the gateways to consumer attention and content discovery.
Nvidia is putting $5 billion into Intel, buying common stock at $23.28 per share for a 4%–5% stake. The two companies plan to co-develop custom PC and data center chips that blend Nvidia’s GPUs with Intel’s x86 CPUs and manufacturing muscle, per ABC News. For Intel, it’s a last chance to remain relevant in advanced computing. For Nvidia, it’s a strategic hedge—ensuring supply resilience and expanding influence over x86 chip design. The partnership will reshape the semiconductor industry and strengthen US tech leadership.
Jimmy Kimmel Live has been pulled off the air after FCC chair Brendan Carr, a Trump appointee, threatened Disney and ABC over the host’s political monologue. Carr called Kimmel “talentless” and suggested the FCC could leverage broadcast license renewals to punish Disney, a move critics see as regulatory overreach. The standoff highlights the growing risk of political retaliation in broadcast media. Advertisers and networks now face new uncertainty: satire has long defined late-night programming, yet even the suggestion of FCC intervention could pressure networks to self-censor and brands to reconsider ad placements.
Olive Garden is testing lower-priced entrées with smaller portion sizes, parent Darden said, to woo consumers who are price-conscious as well as those on weight-loss drugs like Ozempic. Darden’s investments in pricing are helping it win spending from value-conscious consumers, who are looking to get more bang for their buck—and a clear idea of what a night out will cost them. While keeping prices low may hurt short-term profits, the company is confident that its value focus will position it to boost sales and take share.
Amazon sellers using sponsored product ads now have access to Amazon’s Marketing Cloud clean room. Amazon’s expanded access to its clean room solution will enable SMBs to measure and optimize campaigns with the same sophistication as enterprise advertisers while allowing the ad giant to accelerate its push against larger rivals.
Meta is making its boldest play yet for wearable computing, unveiling $799 Meta Ray-Ban Display glasses with a lens display, onboard Meta AI, and a neural wristband for gesture control. Meta won’t stand alone in the field for long if it can prove smart glasses are more than a novelty. Apple, Google, Amazon, and Snap will follow, each layering AR into their ecosystems and competing to define the next advertising frontier. For brands, this means new hooks—ads woven into navigation, translation, and real-world interactions—that feel less like interruptions and more like an extension of everyday life.
While social media drives discovery, it serves primarily as a path to purchase—not as the final destination. Over three-quarters (78%) of US consumers say their purchases are influenced by brands on social media, per Clutch’s From Scroll to Sale report. However, only 15% use social media platforms or apps to make direct purchases. The opportunity in social media commerce lies not just in driving discovery, but closing the gap between interest and action. Brands can earn trust by setting up mechanics like secure checkout to promote cybersecurity and maintaining consistency between marketing voice and website appearance to avoid confusing customers.
As AI fundamentally changes how consumers find products and services, experts continue to explore what marketers must do to adapt. "The most surprising thing, the most pressing thing about AI adoption isn't just that people are starting to use it. It's that they're trusting it, it's that they're using it within their shopping journeys," said EMARKETER analyst Nate Elliott during last week's Future of Digital Summit.
The vast majority (89%) of US adults use generative AI (genAI), per a Centerfield GenAI Consumer Survey commissioned by Search Engine Land. But not everyone uses it the same way. Eighty-seven percent read AI summaries in search results, and the same percentage have used AI for shopping, but only 41% click on a source link after reading a summary. Training and education are top next steps. Keyword research will become less important as competitor analysis ramps up. SEO/GEO specialists need to understand specific user needs and the companies surfacing in AI results to adopt their methods.
Amazon Ads has unveiled an agentic AI tool inside Creative Studio, designed to serve as a real-time creative partner for advertisers. Through a conversational interface, brands can brainstorm, storyboard, and generate professional-quality video and display ads in hours instead of weeks—at no extra cost. Powered by AWS models like Amazon Nova and Anthropic Claude, the system combines retail insights with automation to democratize high-quality ad creation once limited to big-budget brands. Early testers, including Nestlé Health Science, praised its ability to surface new insights and scale campaigns, underscoring how platforms like Amazon, Meta, and Google are redefining advertising.